Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Cue Biopharma (CUE): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
7 analysts
Options Flow (P/C)
—
Avg Consensus PT
$133
+249.6%
Highest Price Target
$300
+689.5%
Lowest Price Target
$60
+57.9%
Short Interest
4.6%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 25, 2025 | LUCID CAPITAL MARKETS | Dev Prasad — | -89.5% | $4 | Initiate | Buy |
| Apr 2, 2025 | Citizens Capital Markets | Reni Benjamin— | -94.7% | $2 → $2 | Maintained | Market Outperform |